<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120818</url>
  </required_header>
  <id_info>
    <org_study_id>yyzhao</org_study_id>
    <nct_id>NCT04120818</nct_id>
  </id_info>
  <brief_title>Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy</brief_title>
  <official_title>Expression Profile of Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>yin ying zhao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective study , a cohort of 58 eyes with congenital cataract from Wenzhou medical
      university was erolled.33 eyes with congenital cataract was after lensectomy and anterior
      vitrectomy as post-surger group, 26 eyes without cataract surgery as control group. The
      cytokines of MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15 was
      evaluated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary IOL implantation in aphika children and lensectomy and anterior vitrectomy and
      primary IOL implantation in children with congenital cataract were both performed by the same
      surgeon(Z.Y.E) and videos were collected to review the capsular reconstruction condition and
      lens implantation position.

      Aqueous humor (100-200 μl) was aspirated from each patient before the surgery. The research
      was to evaluate the relationship between the cytokine profile in aqueous humor and the state
      of capsule after Lensectomy and Anterior Vitrectomy.Aqueous humor was obtained , Human
      Magnetic Luminex Screening Assay was used to determine the aqueous humor levels of cytokines.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 4, 2016</start_date>
  <completion_date type="Actual">February 12, 2017</completion_date>
  <primary_completion_date type="Actual">February 12, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>inflammatory cytokines</measure>
    <time_frame>before the surgery of secondary IOL implantation</time_frame>
    <description>investigate inflammatory microenvironment changes in the aqueous of children after surgery.aqueous humor levels of cytokines, chemokines and growth factors including TGFβ2, TNF-α, IL-6, IP10, IL-10, MCP-1, VEGF, IL-1, IFN-γ, IL-1r,IL-4,IL-17, IL-2,IL-5,G-CSF,IL-12, IL-15.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">59</enrollment>
  <condition>Congenital Cataract</condition>
  <arm_group>
    <arm_group_label>SIOL group</arm_group_label>
    <description>aphakic children diagnosed with congenital cataract who underwent secondary IOL implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PIOL group</arm_group_label>
    <description>children with congenital cataract who underwent lensectomy and anterior vitrectomy and primary IOL implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>secondary IOL implantation</intervention_name>
    <description>reopened the fibrotic, closed capsular bag and achieve IOL placement</description>
    <arm_group_label>SIOL group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>primary IOL implantation</intervention_name>
    <description>lensectomy and anterior vitrectomy and primary IOL implantation</description>
    <arm_group_label>PIOL group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        congenital cataract age from 10 months to 72 months who underwent cataract surgery or
        aphakic children age from 15 months to 72 months who underwent secondary IOL implantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: aphakic children diagnosed with congenital cataract who underwent
        secondary IOL implantation and children with congenital cataract who underwent lensectomy
        and anterior vitrectomy and primary IOL implantation

        Exclusion Criteria:patients with mild cataracts do not require surgery

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Months</minimum_age>
    <maximum_age>72 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hosptial of Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmology and Optometry Hospital</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 19, 2019</study_first_submitted>
  <study_first_submitted_qc>October 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>October 6, 2019</last_update_submitted>
  <last_update_submitted_qc>October 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>yin ying zhao</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>inflammatory cytokines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

